ced pexels 9042094

Endocannabinoid System Research: Cannabis for Anxiety Care

Clinical Takeaway

Cannabis use for anxiety relief produced daily reductions in anxiety, but the effects varied meaningfully depending on whether people used flower or edible products and the cannabinoid content involved. CBD-containing products showed more consistent anxiolytic benefits, while high-THC products demonstrated a more complex relationship with anxiety over time. Patients and clinicians should consider both product type and cannabinoid ratio when evaluating cannabis as part of an anxiety management strategy.

Endocannabinoid System Research: Cannabis for Anxiety Care

#8 Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products.

Citation: Rosa Luiza et al.. Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products.. International journal of environmental research and public health. 2026. PMID: 41752306.

Study type: Journal Article, Randomized Controlled Trial  |  Topic area: Cannabidiol  |  CED Score: 11

Design: 5 Journal: 0 N: 2 Recency: 3 Pop: 2 Human: 1 Risk: -2

Quality Gate Alerts:

  • Preclinical only

Abstract: Research shows that delta-9-tetrahydrocannabinol (THC) is linked to increased anxiety, while cannabidiol (CBD) may have anxiolytic effects. Cannabis use is often driven by coping with anxiety, though its daily impact on anxiety remains unclear. This study examined daily associations between cannabis use and anxiety across 30 days in adults who wanted to use cannabis for anxiety relief. Participants (N = 345) used flower or edible products ad libitum and were randomly assigned to groups by product type (CBD, THC, or THC + CBD). Each day, participants reported cannabis use in the past 24 h and rated their anxiety. Linear mixed-effects models tested whether anxiety changed over time, differed by cannabinoid group, and varied with use. Anxiety significantly decreased over the study period in both flower and edibles groups. In the flower group, THC + CBD and CBD products had greater decreases in anxiety (39.5% and 34.8%, respectively) compared to THC products (7.8%). In the edibles group, when participants used CBD products, this was associated with a 24.9% reduction in anxiety over the 30 days. Findings underscore the importance of distinguishing cannabis effects by product type and cannabinoid composition and suggest that CBD-dominant edibles were associated with less anxiety over time in this naturalistic study.

 |   | 

View on PubMed ↗Full Text ↗DOI ↗